CRYSTAL KUHN: Open Payments
NPI 1700343795 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 96 payments from 23 companies in 2025. Trend: 2023 $2,109 · 2024 $2,421 · 2025 $2,525
Food & beverage: $2,468Education: $57
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $469 |
| GlaxoSmithKline, LLC. | 16 | $375 |
| Verona Pharma, Inc. | 7 | $217 |
| Viatris Specialty LLC | 8 | $211 |
| Regeneron Healthcare Solutions, Inc. | 6 | $159 |
| GENZYME CORPORATION | 4 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| Baxter Healthcare | 5 | $120 |
| Actelion Pharmaceuticals US, Inc. | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $82 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, Ohtuvayre, YUPELRI, TRELEGY ELLIPTA, AIRSUPRA, GLASSIA.
Industry payments across GA — which companies pay providers there.
